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Abstract 
The results of investigation illustrate the lipid peroxidation activation in different tissues under 
the stress influence. The obtained results convince the different resistance of animals to stress. 
The decrease of free and bound oxyprolin content, as well as glycosaminoglycans, which are the 
main components of connective tissue of gingiva, after prolonged stress has been established. 
Stress causes the development of structural and functional disorders in the liver tissue. Melatonin 
is effective to inhibit the stress-induced changes in liver and parodontium. The higher efficiency 
of melatonin at the dose 1,0 mg/kg over 0,2 mg/kg was established. The obtained results open the 
prospects of the using of melatonin and its artificial analogues for pharmacological treatment of 
stress-induced disorders in parodontium and liver. 
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Introduction 
It’s known the stress causes disturbances in 
blood flow, cell hypoxia, prooxidant-antioxidant 
disbalance and the formation of active forms of 
oxygen [1]. The numerous data show the 
development of structural and functional disorders in 
parodontium under the stress influence [2]. The 
development of lipid peroxidation (LPO) 
accompanied with chronic stress provokes the 
morphological and biochemical disorders formation 
in parodontium [3, 4].  
It’s shown that liver is a target organ for stress. 
Stress-induced disorders of liver tissue manifest 
themselves by dystrophy of hepatocytes, the dilation 
of intrahepatic vessels and the disorders of 
hepatocytes regeneration [5]. The stress development 
is accompanied with metabolism disturbances and 
this indicates to the formation of functional disorders 
in liver, because it has a very important role in 
metabolism regulation [6].  
The above-mentioned data make actual the 
investigation of the prevention of stress-induced 
injuries of parodontium and liver. 
Melatonin is one of the main substances of the 
stress-limiting system of a human organism. The 
hormone decreases stress-induced activation of 
hypothalamo-pituitary-adrenal system [7], has an anti-
inflammatory, analgesic [8, 9] and strong antioxidant 
effect, including scavenger of free radicals, 
reinforcement of antioxidant enzymes activity, 
potentiation of the action of another endogenous 
antioxidant [10, 11]. The changes in melatonin content 
in blood were established in patients suffering from 
parodontium diseases [12]. The treatment of 
parodontium disturbances influences the melatonin 
concentration in salivary glands [4]. Nevertheless, the 
effects of melatonin in parodontium of animals exposed 
to stress are not sufficient. 
The stress-induced LPO is one of the most 
important mechanisms of liver injury. Because of it the 
using of melatonin, manifesting of strong antioxidant 
effect can be effective for prevention of stress-induced 
structural and functional disturbances in liver. 
The purpose of this report is the investigation of 
melatonin influence on stress-induced disorders in 
parodontium and liver of animals characterizing by 
different stress-resistance. 
Materials and methods 
The study was conducted on 680 sexually 
mature male albino rats Wistar, weighting 180-220 g, 
obtained from Stolbovaya filial of National Center of 
Biomedical Technologies of Federal 
Medicobiological Agency (NCBMT FMA) (Moscow, 
Russia). The animals were housed in groups of five 
rats per cage. The rats were acclimatized for two 
weeks before using them. The rats were maintained 
under control conditions: temperature 23+-2
o
C, light 
regime: 12 hours light: 12 hours darkness. The 
animals were provided with standard diet containing 
pelleted food and water ad libitum. The experimental 
protocol was based on the principals of Convention 
for defense of vertebrates animals, used for 
experimental and other purposes (Strasbourg, 
France). The University Animal Ethic Committee 
approved this experimental protocol.  
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To separate stress-resistant and stress-
nonresistant rats “open field” test was used [13]. 
“Open field” is a round ground (diameter 1 m), 
divided into 32 sectors by radiuses and 
circumferences. 1 meter over the center of the field 
an electric bulb with routes 60Wt was installed. 
Stress-resistant animals are characterized by: a 
short latent period of the first movement beginning 
(less than 3 s), high horizontal (more than 80 crossed 
sectors) and vertical (more than 10 sets), active 
grooming (more than 10 s), high investigated activity 
(more than 5 peeps in holes), low autonomic balance 
(0-1 boluses). Stress-nonresistant animals have 
opposite characteristics: a long latent period of the 
first movement beginning (more than 10 s), low 
horizontal (less than 40 crossed sectors) and vertical 
(less than 8 sets), rare grooming (less than 4 s), low 
investigated activity (less than peeps in holes), high 
autonomic balance (more than 2 boluses). 
96 stress-resistant and 96 stress-nonresistant rats 
were chosen. Animals which are not related to these 
two groups were excluded from the experiment. 
The prolonged decreased mobility stress model 
was used, in which the animal was set to a special box 
of small volume to prevent any movements without 
food and water for 6 hours during 12 days [14].  
Acute 6-hour immobilization stress was 
produced by the way of animal fixation on the special 
table. The animals were withdrawn from the 
experiment 39 hours, 4 and 7 days after the end of 
immobilization. The choice of these periods is 
determined by the literature data that maximal 
changes in the internal organs are developed at the 
end of alarm stage (39 hours after stress), and 
compensatory reactions in the injured organs are 
manifested obviously at the beginning of resistance 
stage (4 days after stress) and 7 days after stress [5]. 
Melatonin (Aldrich-Sigma, USA) was used in 
the experiments. Melatonin preparation was 
dissolved in 1% ethanol solution. The rats of 
melatonin-treated groups were given melatonin at 
doses 0,2 or 1,0 mg per kg of body weight 
intraperitoneally each day within 7 days after 
prolonged decreased mobility stress modeling. 
Control rats received a similar amount of 1% ethanol 
solution in the same manner. 
The animals exposed to acute immobilization 
stress were given melatonin at doses 0,2 or 1,0 mg 
per kg of body weight intraperitoneally each day 
within 5 days after the experiment beginning. The 
rats sacrificed 39 after stress were given 2 
preparation injections, 4 days – 4 injections.  
On the completion of the experiment the rats 
were sacrificed with ether over dosage. 
39 hours, 4 and 7 days after acute immobilization 
stress modeling and 12 days after prolonged decreased 
mobility stress, animals of each group were 
anaesthetized by ether. Blood was collected directly 
from the heart in heparinized vials. Plasma was 
separated by centrifuging the blood at 3000 rpm at 4
o
C 
for 15 min. The supernatant was used for estimation of 
LPO metabolites malonic dialdehyde (MDA), 
acylhydroperoxides (AHP) concentrations and 
antioxidant enzymes activity: superoxiddismutase 
(SOD) and catalase, as well as the content of albumin, 
plasma protein, cholesterol, triglycerides (TG), non-
esterified fatty acids (NEFA), lipoproteins of very low 
density (LPVLD), lipoproteins of low density (LPLD), 
lipoproteins of high density (LPHD), alanine 
aminotransferase (AlAT) and aspartate 
aminotransferase (AsAT) by traditional methods [15].   
The rats were sacrificed then by ether over 
dosage, and mandible and a piece of liver tissue were 
taken for further investigations. Gingival tissue of a 
half of mandible (100 mg) and a piece of liver tissue 
(100 mg) were homogenized with tissue homogenizer 
in 1 ml of 0,025 mM tris-HCl buffer (pH=7,4). The 
free supernatant of gingiva tissue was obtained by 
centrifugation at 5000 rpm at 4
o
C for 20 min and 
used for estimation of MDA, AHP, free and bound 
oxyprolin, GAG, catalase activities. 
The free supernatant of liver tissue was obtained 
by centrifugation at 5000 rpm at 4
o
C for 20 min and 
used for estimation of MDA, AHP, SOD and catalase 
activities. 
The level of MDA was measured using the 
mixture of thiobarbituric and acetic acids, then optic 
density was measured in 532nm and MDA 
concentration was counted in mcmol/g in gingival 
and liver tissues and mcmol/ml in plasma [16]. The 
level of AHP in specimen was detected in heptan in 
233 nm and expressed in special units [16]. SOD 
activity was detected by method based on the 
determination of the degree of inhibition of nitroblue 
tetrasolium reduction reaction. SOD activity was 
expressed in special units [17]. Catalase activity was 
detected by method based on the capability of  
hydrogen peroxide to form stained complex with 
molibden salts [18]. Catalase activity was counted in 
mcat/g of tissue and mcat/l in plasma. The content of 
free and bound oxyprolin was detected by method 
based on oxyprolin oxidation by chloramin B [19]. 
Clycosaminoglycans (GAG) content was detected by 
using of trichoracetic acid and carbonyl reaction [20]. 
For morphological investigation of parodontium 
the fragment of mandible was fixed in 10% neutral 
formalin with subsequent decalcination. The slides 
from paraffin blocks were prepared (thickness was 5-
6 mcm) and then stained by hemotoxilin+eosin or 
according to Van Gison. The histological and 
planimetry analyses were fulfilled.  
Biochemical analyses were presented as the mean 
+-standard error of means (S.E.M). Comparisons were 
 Lyashev Y.D., Serikov V.S. Melatonin attenuates the stress-induced disorders in parodontium and liver. 
Research result: pharmacology and clinical pharmacology. 2016. Vol. 2, №2: 41-54. 
43 
 
RESEARCH RESULT:  
PHARMACOLOGY AND CLINICAL PHARMACOLOGY 
made between naïve, control (stressed) and stressed 
melatonin-treated groups on computer using “Statistica 
6.0”. A “P” value of 0,05 was selected as a criterion for 
statistically significant differences. 
Results 
The edema of parodontium mucosa, especially 
in the lateral parts, the hyperemia of gingiva and the 
dilation of vessels were observed in stress-resistant 
and stress-nonresistant rats exposed to prolonged 
decreased mobility stress. These changes were more 
expressed in stress-nonresistant rats, and teeth coating 
was revealed in them too.  
The increase of thickness of corneal layer was 
observed in animals of both groups exposed to chronic 
stress. But the thickness of epithelium is significantly 
decreased compared to naïve animals due to prickly and 
granular layers destruction. The dystrophy of epithelium 
is observed mainly in prickly and granular layers. The 
loosening of epithelium develops as the result of edema. 
There are a lot of macrophages and neutrophils in the 
epithelium layer. The dilation of vessels and increase of 
fibroblasts amount are observed in propria lamina. It is 
infiltrated by neutrophils and macrophages. The 
decrease of the thickness of cortical laminas and bone 
trabecules of spongy tissue is revealed in peripheral 
regions. All the indicated changes are  obviously 
observed in stress-nonresistant animals, in which 
leukocyte infiltration and generalized thinning of 
parodontium bone tissue are more expressed (Picture 1).  
 
 
Figure 1. Stress-induced changes in parodontium of stress-nonresistant control animals: the decrease of epithelium thickness, 
edema, leukocyte infiltration of lamina propria. Hematoxilin&eosin. X 100. 
 
The administration of melatonin to the animals 
of both groups caused the weakening of stress-
induced parodontium disorders. Although hyperemia 
was present, but the edema of mucosa was absent, 
excepting some stress-nonresistant rats. Tooth 
coating was not determined. 
The microscope examination revealed the 
increase of epithelium thickness, minor dystrophic 
changes in epithelium compared to the corresponding 
control group. The edema and the number of dilated 
vessels were significantly fewer in all the groups of 
melatonin-treated animals compared to control rats. 
The administration of melatonin prevented the stress-
induced changes in the parodontium bone tissue. 
Cortical lamina and trabecules of spongy bones had 
almost normal thickness. The effects of the 
investigated preparation were more expressed at the 
dose of 1,0 mg per kg b.w (Picture 2). 
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Figure 2. Stress-induced changes in parodontium of stress-nonresistant animals treated with melatonin at the dose 1,0 mg/kg: the 
decrease of epithelium thickness, edema, leukocyte infiltration of lamina propria are weakly expressed. Hematoxilin&eosin. X 100. 
 
MDA and AHP concentrations were increased in 
gingival tissue in both stress-resistant and stress-
nonresistant rats after 12-days of decreased mobility 
stress. The drop of catalase activity was observed in 
stress-nonresistant animals, but not in stress-resistant 
ones. It has shown the decrease of free and bound 
oxyprolin and GAG in the gingival tissue of  rats after  
stress. The obtained results are shown in Tables 1 and 2. 
Table 1 
The influence of melatonin on the content of bound oxyprolin, glycoaminoglycans, malonic dialdehyde, 
acylhydroperoxides and catalase activity in gingival tissue of stress-resistant rats after chronic stress (M+-m; n=8) 
Index 
Group 
Content 
of free 
oxyprolin 
in 
gingiva, 
mmol/g 
Content of 
bound 
oxyprolin 
in gingiva, 
mmol/g 
Content of 
glycosaminoglycans 
in gingiva, mg/g 
Content of 
malonic 
dialdehyde in 
gingiva, 
mcmol/g 
Content of 
acyhydroperoxides 
in gingiva, s.u. 
Catalase 
activity in 
gingiva, 
mcat/g 
Naive (intact) 5,80±0,30 5,86±0,26 7,43±0,30 13,28±0,39 3,83±0,25 27,29±0,55 
Control 
(stressed) 
5,19±0,23 5,49±0,28 7,15±0,33 16,14±0,60хх 5,30±0,39х 26,55±0,49 
Stress+melatonin 
at the dose 1 
mg/kg 
5,74±0,30 5,88±0,27 7,09±0,35 14,21±0,38* 3,90±0,29* 23,69±0,36** 
Stress+melatonin 
at the dose 0,2 
mg/kg 
5,71±0,31 5,98±0,32 7,00±0,48 15,04±0,57 4,84±0,38 26,49±0,60 
 
Note: 
х
 – at p<0.05 as compared to intact rats, хх – at p<0.01 as compared to intact rats. * - at p<0.05 as compared to control 
rats, ** – at p<0.01 as compared to control rats. 
 Lyashev Y.D., Serikov V.S. Melatonin attenuates the stress-induced disorders in parodontium and liver. 
Research result: pharmacology and clinical pharmacology. 2016. Vol. 2, №2: 41-54. 
45 
 
RESEARCH RESULT:  
PHARMACOLOGY AND CLINICAL PHARMACOLOGY 
The injections of melatonin solution at the 
dose 1,0 mg per kg of b.w. within 7 days inhibited 
the lipid peroxidation in gingival tissue in both 
investigated groups of rats, that was manifested with 
the reduction of MDA and AHP concentrations. The 
preparation administration had opposite effects on 
catalase activity in gingiva of rats after stress. The 
decrease of this enzyme activity was observed in 
stress-resistant rats and the increase - in stress-
nonresistant. Besides the increase of free and bound 
oxyprolin and glycosaminoglycans was detected only 
after stress in gingiva of stress-nonresistant rats, 
which received hormone injections. 
Table 2 
The influence of melatonin on the content of bound oxyprolin, glycoaminoglycans, malonic dialdehyde, 
acylhydroperoxides and catalase activity in gingival tissue of stress-nonresistant rats after chronic stress (M+-m; n=8) 
 
Index 
 
 
Group 
Content of 
free 
oxyprolin in 
gingiva, 
mmol/g 
Content of 
bound 
oxyprolin in 
gingiva, 
mmol/g 
Content of 
glycosaminoglyc
ans in gingiva, 
mg/g 
Content of 
malonic 
dialdehyde in 
gingiva, 
mcmol/g 
Content of 
acyhydroperoxi
des in gingiva, 
s.u. 
Catalase 
activity in 
gingiva, mcat/g 
Naive (intact) 6,21±0,25 6,59±0,29 7,38±0,40 14,06±0,41 3,96±0,19 26,24±0,66 
Control (stressed)  4,24±0,38 4,46±0, 5,54±0,27хх 19,63±0,73ххх 5,65±0,37хх 22,69±0,67хх 
Stress+melatonin 
at the dose 1,0 
mg/kg 
5,51±0,32* 5,78±0,34* 6,84±0,31* 16,64±0,79* 4,50±0,31* 25,81±0,77* 
Stress+melatonin 
at the dose 0,2 
mg/kg 
4,59±0,27 5,34±0,38 6,56±0,35* 17,05±0,73* 4,53±0,40* 25,61±0,54* 
 
Note: 
хx
 – at p<0.01 as compared to intact rats, xxx – at p<0.001 as compared to intact rats. * - at p<0.05 as compared to control rats. 
 
 
 
The administration of melatonin at the dose 0,2 
mg per kg of b.w. had antioxidant effect in stress-
nonresistant rats after stress, but not in stress-resistant 
ones. It was established that MDA and AHP, catalase 
activity decreased in them. The injections of 
preparation at small dose caused the increase of GAG 
content, but not free and bound oxyprolin in gingiva 
of stress-nonresistant rats after stress. 
In both groups of rats, exposed to 6-hour 
immobilization stress, the decrease of the thickness 
of granular layer was determined 39 hours and 4 days 
after stress modeling. In stress-nonresistant animals, 
the rare dystrophy of epithelial cells was considered. 
Infiltration of epithelial layer by macrophages and 
neutrophils is not evident. In some preparations the 
decrease of the thickness of cortical laminas and bone 
trabecules are revealed. The effects of melatonin on 
the morphological changes in parodontium in the 
both investigated groups are not determined. 
The modeling of 6-hour immobilization stress 
causes the shift of prooxidant-antioxidant balance in 
the mucosa of parodontium of stress-resistant animals 
39 hours after the experiment beginning, that 
manifested by the increase of the content of LPO 
intermediate metabolites – AHP (by 24,9%, p<0,05), 
there was no increase of MDA concentration  and 
changes in catalase activity.  
The arising of LPO metabolites was observed in 
stress-nonresistant rats 39 hours after 6-hour 
immobilization stress: AHP – by 44,1% (p<0,01) and 
MDA – by 18,7% (p<0,05). The catalase activity was 
not changed.  
There were no differences between rats, exposed 
to stress, and naïve ones of corresponding typological 
group on the fourth and the seventh days after the 
experiment beginning.  
The administration of melatonin at the dose 1,0 
mg per kg b.w. caused the suppression of LPO, 
manifested by the decrease of AHP content by 10,3% 
in stress-resistant rats, exposed to 6-hour 
immobilization stress compared to control animals. 
The injections of melatonin at the dose 0,2 mg per kg 
had no influence on LPO.  
The decrease of LPO in parodontium mucosa is 
observed in melatonin-treated (dose is 1,0 mg per kg 
b.w.)  stress-nonresistant rats 39 hours after stress 
modeling. MDA concentration was less in them by 
16,4% (p<0,05) compared to control ones. The 
normal level of LPO and catalase activity was 
revealed in melatonin-treated animals, exposed to 
immobilization stress, on the fourth and the seventh 
days after stress modeling.  
There were no changes in the content of 
collagen and GAG in parodontium in the rats, 
exposed to 6-hour immobilization stress.  
The modeling of prolonged decreased mobility 
stress caused the following changes in liver tissue 
microstructure in stress-resistant animals: the 
decrease of normal hepatocytes number by 11,0% 
(p<0,001), the increase of dystrophic cells by 70,4% 
(p<0,001), the increase of the specific area of 
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dystrophic regions of cytoplasm in 4,4 times 
(p<0,001) compared to naïve animals (Table 3). The 
sum volume of sinusoids was increased by 60,5% 
(p<0,001), that indicates to disturbances in liver 
tissue microcirculation.  
Table 3 
The influence of melatonin on morphological changes in liver tissue after prolonged decreased  
mobility stress (M+-m; n=8)  
 
Index 
 
 
 
 
Group 
The share of 
normal 
hepatocytes, 
% 
The share 
of 
dystrophi
c 
hepatocyt
es,  % 
Specific area 
of 
dystrophicall
y changed 
cytoplasm 
regions, sp. 
un. 
The overage 
volume of 
nuclei, sp. un. 
The share 
of binuclear 
hepatocytes
, % 
The share 
of nuclei 
containing 
one 
nucleolus, 
% 
Sum 
volume of 
sinusoids, 
% 
Sum 
volume of 
stroma, sp. 
un. 
Stress-resistant 
naïve (intact) 
86,5±0,6 13,6±0,6 0,05±0,01 0,23±0,01 18,5±0,9 83,8±0,7 8,6±0,5 0,18±0,01 
Stress-resistant 
stressed  
77,0±1,0ххх 
23,0±1,0х
хх
 
0,22±0,02ххх 0,27±0,01хх 25,9±1,1ххх 73,9±1,5ххх 13,8±0,5хх 0,20±0,01 
Stress-resistant 
stressed + 
melatonin at the 
dose 0,2 mg/kg  
76,5±1,4 23,5±1,4 0,19±0,02 0,26±0,01 26,1±1,1 72,9±1,3 12,0±0,4* 0,20±0,01 
Stress-resistant 
stressed + 
melatonin at the 
dose 1,0 mg/kg  
80,9±1,0* 19,1±1,0* 0,16±0,01* 0,28±0,01 29,5±0,7* 65,8±1,4** 11,6±0,5* 0,20±0,01 
Stress-
nonresistant naïve 
(intact) 
84,8±1,2 15,2±1,2 0,06±0,01 0,21±0,01 19,6±0,8 85,3±1,1 10,5±0,4 0,19±0,01 
Stress-
nonresistant 
stressed  
51,3±1,3ххх 
48,7±1,3х
хх
 
0,48±0,04ххх 0,26±0,01 23,3±1,0х 72,8±1,1ххх 19,3±0,7ххх 0,21±0,01 
Stress-
nonresistant 
stressed + 
melatonin at the 
dose 0,2 mg/kg  
69,9±1,5*** 
30,1±1,5*
** 
0,36±0,03* 0,24±0,01 26,3±0,8* 70,9±1,4 18,6±0,5 0,20±0,01 
Stress-
nonresistant 
stressed + 
melatonin at the 
dose 1,0 mg/kg  
73,3±1,9*** 
26,7±1,9*
** 
0,32±0,03** 0,28±0,01 27,0±0,8* 67,6±1,5* 16,5±0,7* 0,20±0,01 
 
Note: 
x
 – at p<0.05 as compared to intact rats,  хx – at p<0.01 as compared to intact rats, xxx – at p<0.001 as compared to intact 
rats. * - at p<0.05 as compared to control rats, *** - at p<0.001 as compared to control rats. 
 
The activation of reparative processes was observed 
simultaneously in liver tissue: the overage size of nuclei 
was increased by 17,4% (p<0,05), the share of two-
nuclear hepatocytes arose by 40,0% (p<0,01), the share 
of nuclei containing one nucleolus was decreased by 
11,9% (p<0,001) (Picture 3). 
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Figure 3. Dystrophy of hepatocytes of stress-resistant rats, exposed to prolonged decreased mobility stress. The number of 
dystrophic cell is low. Hematoxilin&eosin. X 140. 
 
 
The modeling of prolonged decreased mobility 
stress to stress-nonresistant rats caused a significant 
increase of dystrophic hepatocytes by 3,2 times 
(p<0,001) and the decrease of normal hepatocytes 
amount by 39,5% (p<0,001). The increase of the 
specific area of dystrophically changed cytoplasm 
regions by 7,3 times (p<0,001) was observed in them 
compared to naïve animals. The sum volume of 
sinusoids was increased by 96,9% (p<0,001)  
(Picture 4) 
The activation of reparative processes in this 
group manifested itself by increase of overage size of 
nuclei by 23,8% (p<0,01), the decrease of the share 
of nuclei containing one nucleolus by 8,7% (p<0,01).  
Pharmacological effects of melatonin at the dose 
1,0 mg per kg in stress-nonresistant rats include the 
significant decrease of the dystrophic hepatocytes 
number by 45,2% (p<0,001), the increase of normal 
hepatocytes by 42,9% (p<0,001), the decrease of the 
specific area of dystrophically changes cytoplasm 
regions by 31,8% (p<0,05), the drop of the sum 
volume of sinusoids by 14,5% (p<0,05), the arising 
of the share two-nuclear hepatocytes by 19,4% 
(p<0,01) and the decrease of the share of nuclei 
containing one nucleolus by 11,8% (p<0,01). The 
effects of melatonin at the dose 0,2 mg per kg has the 
same direction but less.  
 
. 
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Figure 4.  Dystrophy of hepatocytes of stress-nonresistant rats, exposed to prolonged decreased mobility stress. The number of 
dystrophic cell is high and heterogeneity of cytoplasm is expressed. Hematoxilin&eosin. X 140 
 
 
The modeling of  6-hour immobilization stress 
caused significant increase of dystrophic hepatocytes, 
the decrease of normal hepatocytes number, the 
increase of specific area of dystrophically changed 
cytoplasm regions, the increase of sum volume of 
sinusoids in stress-resistant and stress-nonresistant 
rats 39 hours and 4 days after the experiment 
beginning. The activation of reparative processes in 
liver parenchyma becomes evident on the fourth day 
of the experiment and manifested itself by the 
increase of the share of two-nuclear hepatocytes and 
the decrease of the share of nuclei containing one 
nucleolus. There were no differences in all the 
investigated indices between rats, exposed to 6-hour 
immobilization stress, and naïve ones 7 days after 
stress modeling.   
The administration of melatonin at the doses 1,0 
and 0,2 mg per kg caused the decrease of the share of 
nuclei containing one nucleolus in stress-resistant rats 
39 hours after immobilization (by 5,3% and 6,5% 
correspondently, p<0,05). Stress-limiting effects of 
melatonin at the dose 1,0 mg per kg are the most 
evident on the fourth day of the experiment: the 
decrease of dystrophic hepatocytes by 29,2% 
(p<0,01), the increase of normal hepatocytes number 
by 6,2% (p<0,01), the decrease of the specific area of 
dystrophically changed cytoplasm regions by 36,4% 
(p<0,05), the decrease of sum volume of sinusoids by 
19,8% (p<0,05) compared to control animals. The 
activation of reparative processes in the liver tissue 
manifested itself by less share of nuclei containing 
one nucleolus (by 4,5%, p<0,01). The animals, 
treated by melatonin at the dose 0,2 mg per kg b.w., 
were characterized by decreased sum volume of 
sinusoids (by 16,5%, p<0,05).  The stress-limiting 
effect of melatonin at the dose 1,0 mg per kg was 
evident on the seventh day too.  
The significant decrease of the specific area of 
dystrophically changed cytoplasm regions by 33,3% 
and 38,1% correspondently is revealed in stress-
nonresistant rats compared to control group 39 hours 
after the experiment (p<0,001). Melatonin-treated 
stress-nonresistant animals (dose 1,0 mg per kg b.w.) 
showed the significant decrease of dystrophic 
hepatocytes number (by 22,3%, p<0,01) and increase 
of normal hepatocytes amount (by 4,9%, p<0,01).  
The activation of reparative processes in liver tissue 
of melatonin-treated rats, exposed to 6-hour 
immobilization stress, is confirmed by the significant 
increase of the share of binuclear hepatocytes (by 
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9,1%, p<0,05) and the decrease of the share of nuclei 
containing one nucleolus (by 4,2%, p<0,05).  
The administration of preparation at the dose 0,2 
mg per kg didn’t affect the investigated parameters in 
stress-nonresistant animals on the fourth day of the 
experiment.  
The administration of melatonin at the doses 1,0 
and 0,2 mg per kg b.w. increased the share of 
binuclear hepatocytes in stress-nonresistant animals 
on the seventh day of the experiment compared to the 
control group (p<0,01). 
The modeling of prolonged decreased mobility 
stress is accompanied with the increase of the content 
of LPO metabolites in liver tissue (Table 4). Besides, 
the activity of antioxidant enzymes was inhibited, 
that indicates to the suppression of adaptation 
processes in the organ.  
Table 4 
Influence of melatonin on the content of lipid peroxidation metabolites and antioxidant enzymes activity in liver tissue 
in prolonged decreased mobility stress  (M+-m; n=8) 
 
Indices 
 
Group 
Content of  malonic 
dialdehyde, 
mcmol/l 
Content of 
acylhydroperoxidesides,  su 
Superoxidismutase 
activity, su 
Catalase activity, 
mcat/ml 
Naïve (intact) 32,1±1,5 4,4±0,3 54,5±1,9 48,4±1,7 
Control (stressed)  48,4±2,4xxx 9,6±0,6xxx 34,2±1,3xxx 28,4±1,8xx 
Stressed + melatonin 
at the dose 0,2 
mg/kg  
41,0±1,7* 6,2±0,4** 40,7±1,4** 38,6±1,4** 
Stressed + melatonin 
at the dose 1,0 
mg/kg  
38,6±1,7** 6,1±0,4** 46,8±1,5*** 40,5±1,5*** 
Note: 
хx
 – at p<0.01as compared to intact rats, ххx – at p<0.001as compared to intact rats, * - at p<0.05 as compared to control 
rats, ** - at p<0.01 as compared to control rats, *** - at p<0.001 as compared to control rats. 
 
 
Intraperitoneal injections of melatonin at the 
dose 1,0 mg per kg b.w. within 7 day of stress 
modeling caused the decrease of LPO metabolites 
concentration: MDA – by 20,2% (p<0,01) and AHP – 
by 37,2% (p<0,01) compared to control group. The 
activity of investigated enzymes was increased: SOD 
– by 36,8% (p<0,01) and catalase – by 42,5% 
(p<0,001). The effect of melatonin at the dose 0,2 mg 
per kg  were the same but its expression was less. 
The development of acute immobilization stress 
is accompanied with prooxidant-antioxidant balance 
disorders, LPO activation in the liver tissue. The 
activity of both antioxidant enzymes in rats, exposed 
to acute immobilization stress, was suppressed in 
liver tissue. 
The pharmacological antioxidant effect of 
melatonin at the dose 1,0 mg per kg was significantly 
more expressed. The concentrations of MDA and 
AHP were less compared to control group 39 hours 
after stress modeling and besides these were almost 
the same to MDA and AHP value in naïve animals 4 
days after the experiment beginning.  
There were no differences between the 
concentrations of LPO metabolites, AlAT, AsAT, 
general protein, albumin, cholesterol, TG, NEFA, 
LPVLD, LPLD, LPHD of stress-resistant and stress-
nonresistant animals in our investigation, because of it 
the data of biochemical investigation in plasma are 
presented without the separation of typological groups. 
The development of acute 6-hour 
immobilization stress causes the increase of AlAT 
and AsAT content, the decrease of plasma protein 
content 39 hours after immobilization stress. 
Albumin concentration was decreased compared to 
naïve animals by 3,5% (p<0,05) 4 and 7 days after 
stress modeling. The administration of melatonin at 
the dose 1,0 mg per kg b.w. caused the decrease of 
AlAT concentration by 20,0% and AsAT one by 
22,2% (p<0,05) compared to control group 39 hours 
after stress. Melatonin injections had no effect on the 
concentration of general protein and albumin in 
animals, exposed to 6-hour immobilization stress 
(Table 5). 
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Table 5 
The influence of melatonin on the concentration of AsAT, AlAT, general proteins, albumins, glucose in the plasma  
of animals, exposed to 6-hour immobilization stress (M+-m; n=8) 
Index 
 
Group 
The period after 
immobilization 
Aspartate 
aminotransferase, 
un/l 
Alanine 
aminotransferas
e, un/l 
Albumin, g/l 
General 
protein, g/l 
Glucose, 
mrmol/l 
Naive (intact) group 196,6±12,1 55,5±3,5 31,0±0,2 67,9±1,2 8,4±0,2 
Control (stressed) 
group 
39 h. 499,9±32,6ххх 166,6±12,2ххх 30,7±0,4 64,3±0,6х 8,5±0,2 
4 days 215,1±21,9 55,5±5,9 29,9±0,4х 69,8±1,0 8,9±0,2 
7 days 188,8±6,9 59,0±4,3 29,5±0,4х 67,4±1,3 8,6±0,3 
Stressed group + 
melatonin at the 
dose 0,2 mg/kg 
39 h. 443,0±16,4ххх 143,9±3,0ххх 29,5±0,4х 64,4±0,7х 9,0±0,3 
4 days 217,3±14,6 59,6±5,6 29,4±0,5х 68,6±1,1 9,1±0,3 
7 days 205,3±11,1 55,2±5,8 29,4±0,3 68,0±1,4 9,1±0,3 
Stressed group + 
melatonin at the 
dose 1,0 mg/kg 
39 h. 399,6±2,3*ххх 129,5±3,9*ххх 29,5±0,4х 63,8±0,6 9,0±0,3 
4 days 185,9±15,0 62,8±5,6 29,8±03х 66,5±1,4 8,6±0,3 
7 days 159,4±6,1 57,8±4,2 29,6±0,3х 66,8±0,9 8,7±0,2 
Note: 
х
 – at p<0.05as compared to intact rats, ххx – at p<0.001as compared to intact rats, * - at p<0.05 as compared to control rats. 
 
The modeling of prolonged decreased mobility 
stress within 12 days caused the arising of AlAT and 
AsAT content in plasma by 2,6 and 3,6 times 
correspondently (p<0,001) (Table 6). The drop of 
albumin plasma concentration by 8,1% was revealed 
(p<0,01). The administration of melatonin at the 
doses 1,0 and 0,2 mg per kg b.w. resulted in 
significant decrease of AlAT and AsAT 
concentrations in plasma (p<0,01-0,001). Albumin 
content was significantly higher than in the control 
group (p<0,05-0,01).  
The prolonged decreased mobility stress caused 
the disorders of prooxidant-antioxidant balance in 
blood plasma. The concentrations of LPO metabolites 
were increased: MDA – up to 92,6%, AHP – up to 
134,1% (p<0,001) compared to naïve animals (Table 
7). The activity of antioxidant enzymes in plasma 
was significantly suppressed: SOD – by 48,1%, 
catalase - by 28,2% (p<0,001).  
Table 6 
The influence of melatonin on the concentration of AsAT, AlAT, general proteins, albumins, glucose in the plasma of 
animals, exposed to prolonged decreased mobility stress (M+-m; n=8) 
Index 
 
Group 
Aspartate 
aminotransferase, un/l 
Alanine 
aminotransferase, 
un/l 
Albumin, g/l 
General 
protein, g/l 
Glucose, 
mrmol/l 
Naïve (intact) group 203,3±8,7 54,5±3,2 29,7±0,4 67,1±1,8 8,5±0,2 
Control (stressed) 
group  
536,6±15,5ххх 198,3±8,7ххх 27,3±0,4хх 63,3±0,9 8,5±0,2 
Stressed group + 
melatonin at the dose 
0,2 mg/kg  
479,3±18,4** 153,0±7,8* 29,4±0,4** 67,8±1,2 8,8±0,2 
Stressed group + 
melatonin at the dose 
1,0 mg/kg  
421,8±18,2*** 134,4±7,3** 29,3±0,5* 67,5±1,1 8,7±0,3 
Note: 
хx
 – at p<0.01 as compared to intact rats, ххx – at p<0.001 as compared to intact rats, * - at p<0.05 as compared to control 
rats,  ** - at p<0.01 as compared to control rats,  *** - at p<0.001 as compared to control rats. 
Table 7 
Influence of melatonin on the content of lipid peroxidation metabolites and antioxidant enzymes activity in plasma  
in prolonged decreased mobility stress (M+-m; n=8) 
Indices 
 
Group 
Content of  malonic 
dialdehyde in plasma 
mcmol/l 
Content of 
acylhydroperoxidesiin 
plasma,  su 
Superoxidismutase 
activity in plasma, su 
Catalase activity in 
plasma, 
mcat/ml, 
Naïve (intact) 13,9±0,7 5,6±0,3 22,3±1,2 25,0±1,1 
Control (stressed)  26,8±0,9xxx 13,2±0,5xxx 11,6±0,4xxx 17,9±0,4xxx 
Stressed + melatonin 
at the dose 0,2 mg/kg  
17,1±0,9*** 8,2±0,5*** 14,7±0,8** 19,8±0,7 
Stressed + melatonin 
at the dose 1,0 mg/kg  
16,0±0,7*** 7,7±0,6*** 18,4±1,1*** 22,9±1,1** 
Note: 
хx
 – at p<0.01as compared to intact rats, ххx – at p<0.001as compared to intact rats, * - at p<0.05 as compared to control 
rats, ** - at p<0.01 as compared to control rats, *** - at p<0.001 as compared to control rats. 
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The intraperitoneal injections of melatonin at the 
dose 0,2 mg per 1 kg of b.w. within 7 days of stress 
modeling decreased significantly the content of MDA 
(by 36,3%) and AHP (by 37,6%) (p<0,001). But 
these values were higher than the same parameters in 
naïve rats (p<0,05). SOD activity was increased by 
20,9% compared to control group (p<0,01). Catalase 
activity was not changed significantly under the 
influence of melatonin at the dose 0,2 mg per kg b.w.  
However the activities of both investigated enzymes 
were lower than the same parameters in naïve rats 
(p<0,05-0,01).   
The antioxidant effects of melatonin at the dose 
1,0 mg per kg of b.w. were stronger than those in 
lower dose. The concentration of LPO metabolites 
were significantly less compared to control group: 
MDA – by 40,3%, AHP – by 41,9%. The activities of 
antioxidant enzymes were higher than in the control 
group: SOD – by 58,6% (p<0,001), catalase – by 
22,5% (p<0,01). It’s important that there were no 
differences in enzymes activities between naïve 
animals and ones, treated by melatonin at the dose 
1,0 mg per kg b.w. 
As in the liver tissue the modeling of 6 hour 
immobilization stress was accompanied by the 
increase of MDA and AHP concentrations in plasma, 
but the changes in the antioxidant enzyme activity 
had opposite directions: SOD – was increased and 
catalase – was decreased within 4 days after stress 
modeling.  
The administration of melatonin at the both 
investigated doses suppressed LPO and the 
pharmacological effects of the preparation at the dose 
1,0 mg per kg b.w. was significantly more expressed. 
If the decrease of MDA only was revealed after the 
injections of the dose 0,2 mg per kg b.w., the drop of 
both MDA and AHP concentration was observed  in 
melatonin-treated animals at the dose 1,0 mg per kg 
b.w. Besides the content of LPO metabolites in this 
group on the fourth day after acute stress was 
approximately equal to that one in naïve rats.  
The modeling of prolonged decreased mobility 
stress caused significant increase of cholesterol, TG, 
NEFA concentrations (by 70,2%, 42,6%, 174,6% 
correspondently, p<0,01-0,001) (Table 8). The 
administration of melatonin at the dose 1,0 mg per kg 
b.w. is accompanied with the drop of the content of: 
cholesterol – by 30,6% compared to control group. 
Melatonin injections at the dose 0,2 mg per kg b.w. 
caused less effects.  
Table 8.  
The influence of melatonin on the content of cholesterol, triglycerides, nonesterified fatty acids and lipoprotein of 
different density in plasma of rats, exposed to prolonged decreased mobility stress. (M+-m; n=8) 
 Index 
 
Group 
Cholesterol 
mmol/l 
TG, mmol/l  
LPVLD, 
mmol/l  
LPLD, mmol/l  
LPHD, 
mmol/l  
NEFA, mmol/l  
Naïve (intact) 
group 
2,08±0,08 1,69±0,11 0,06±0,01 0,06±0,01 0,27±0,02 0,67±0,04 
Control (stressed) 
group  
3,56± 0.09xxx 2,44± 0,11 xx 0,15±0,01 xxx 0,16±0,01 x 0,17±0,01 xx 1,98±0,10 xxx 
Stressed group + 
melatonin at the 
dose 1,0 mg/kg  
2,47±0,09*** 1,97±0,09** 0,14±0,01 0,14±0,01 0,28±0,03** 1,32±0,05*** 
Stressed group + 
melatonin at the 
dose 0,2 mg/kg  
2,80±0,10*** 2,15±0,10 0,15±0,01 0,15±0,01 0,25±0,03* 1,40±0,08** 
Note: 
х
 – at p<0.05 as compared to intact rats,  хx – at p<0.01as compared to intact rats, ххx – at p<0.001 as compared to intact rats,  * - 
as p<0.05 as compared to control rats,  ** - at p<0.01 as compared to control rats,  *** - at p<0.001 as compared to control rats. 
 
The changes in the content of different types of 
LP were revealed in animals, exposed to prolonged 
decreased mobility stress: LPVLD and LPLD 
concentrations were increased by 166,7% and 
150,0% correspondently (p<0,001), but LPHD one 
was less by 40,7% (p<0,01).  
Melatonin-treated animals (at the both doses) 
were characterized by higher concentration of LPHD 
than in control group, but there were no differences 
in the content of LPVLD and LPLD.  
The modeling of 6 hour immobilization stress 
caused the increase of the concentrations of: 
cholesterol – by 54,4% (p<0,001), TG – by 38,0% 
(p<0,01), LPVLD – by 36,0% (p<0,001), LPLD – by 
61,9% (p<0,001), NEFA – by 136,7% (p<0,001) 39 
hours after immobilization (Table 9). LPHD 
concentration was not significantly changed. The 
high content of NEFA remained higher than in the 
naïve group (by 49,4%, p<0,05). The increase of 
LPHD concentration was revealed 4 day after stress 
modeling. 
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Table 9 
The influence of melatonin on lipid metabolism indices at the different periods after 6-hour immobilization (M+-m; n=8) 
Index 
 
 
Group 
The 
period 
after 
immobil
ization  
Cholesterol 
mmol/l 
TG, mmol/l  
LPVLD, 
mmol/l  
LPLD, 
mmol/l  
LPHD, 
mmol/l  
NEFA, 
mmol/l  
Naive (intact) group 2,04±0,02 1,79±0,12 0,25±0,02 0,21±0,02 1,20±0,05 0,79±0,07 
Control 
(stressed) group 
39 h. 3,15±0,16ххх 2,47±0,10хх 0,34±0,03ххх 0,34±0,03ххх 1,19±0,03 1,87±0,09ххх 
4 days 2,19±0,05 2,01±0,11 0,20±0,02 0,19±0,02 1,35±0,05 1,18±0,09х 
7 days 1,88±0,09 1,73±0,13 0,17±0,01хх 0,16±0,01 1,17±0,05 0,79±0,09 
Stressed group + 
melatonin at the 
dose 0,2 mg/kg 
39 h. 2,91±0,19 2,31±0,17 0,35±0,04 0,34±0,04 1,39±0,06* 1,91±0,10 
4 days 2,16±0,11 1,61±0,17 0,21±0,02 0,22±0,03 1,03±0,08* 0,92±0,09 
7 days 1,90±0,15 1,91±0,15 0,20±0,02 0,19±0,02 1,17±0,06 0,69±0,11 
Stressed group + 
melatonin at the 
dose 1,0 mg/kg 
39 h. 2,77±0,13 2.22±0,13 0,34±0,03 0,35±0,03 1,52±0,08*
* 
1,79±0,09 
4 days 2,08±0,09 1,72±0,15 0,26±0,02 0,26±0,02* 1,27±0,06 0,76±0,06** 
7 days 2,06±0,11 1,76±0,09 0,20±0,02 0,21±0,02 1,55±0,04*
** 
0,74±0,07 
Note: 
х
 – at p<0.05 as compared to intact rats,  хx – at p<0.01 as compared to intact rats, ххx – at p<0.001 as compared to intact rats,  * - 
at p<0.05 as compared to control rats,  ** - at p<0.01 as compared to control rats,  *** - at p<0.001as compared to control rats. 
 
The administration of melatonin at the both 
investigated doses had no significant influence on 
these indices. The increase of LPHD content was 
revealed 39 hours after the experiment beginning.  
Discussion 
The results of our investigation proove the 
recently obtained evidence which illustrates the LPO 
activation in different tissues under the stress 
influence [1]. We found the accumulation of MDA 
and AHP in gingival tissue, liver tissue and plasma of 
rats after immobilization stress. The obtained results 
demonstrate different resistance of animals to stress. 
That is manifested by higher increase of LPO 
metabolites as well as the inhibition of antioxidant 
enzymes activity in investigated tissues and plasma 
of stress-nonresistant rats compared to stress-resistant 
ones. Multiple reports explain low resistance to stress 
in animals by insufficiency of stress-limiting 
mechanisms in them [21].  
Some investigators point to close connection 
between LPO activation and changes in the chemical 
composition of parodontium [22]. It was established 
that the free and bound oxyprolin content was 
decreased, that means the reduction of collagen 
content as well as GAG, which are the main 
components of connective tissue matrix of gingiva. 
Our investigation confirm the literature data that 
stress causes the development of structural disorders 
in the liver tissue, including the dilation of sinuses, 
dystrophy of hepatocytes, and simultaneously the 
reparative processes take place in the liver [5].    The 
principal mechanism stimulating the formation of 
hepatocytes injury is stress-induced activation of 
LPO [23]. It’s known that the stress  and 
hyperactivation of adrenergic mechanisms lead to the 
microcirculation disorders and hypoxia of tissue – the 
factors providing the LPO activation.  
The functional disturbances in hepatocytes were 
established in this report manifesting by the 
suppression of protein and lipoprotein synthesis. It’s 
known the main type of lipoproteins in rats is LPHD 
[24], which become manifest with antioxidant 
properties [24]. So, the stress causes the inhibition of 
different parts of antioxidant system: enzymes (SOD 
and catalase) and the scavengers of radicals.  
The results of our investigation confirm the 
typical disorders of lipid metabolism in rats exposed 
to stress: TG, cholesterol, NEFA concentrations 
increase in plasma [24]. These effects are explained 
by stimulatory influence of catecholamines on 
adipocytes and decreased insulin secretion, that is 
accompanied with the mobilization of TG and 
esterification of  NEFA due to adenylate cyclase 
activation [24]. These changes are the manifestations 
of metabolism shift from carbohydrate to lipid 
pathway [25]. The increase of cholesterol 
concentration is explained by the inhibition of its 
destruction in the liver due to the accumulation of 
LPO metabolites, which inhibit the main enzyme of 
cholesterol catabolism – 7-alpha-hydroxilase [26]. 
Stress causes the increase of NEFA concentration in 
plasma, which is the strongest stimulus of LPVLD 
and LPLD formation [24].  
The decrease of general protein content 39 hours 
after stress modeling and albumin concentration 4 
days after immobilization were established in our 
investigation. The drop of albumin, but not general 
protein was observed in animals exposed to 
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prolonged decreased mobility stress. We guess that 
the decrease of general protein 39 hours after stress 
modeling is the result of stress-induced proteolysis 
activation. The suppression of protein synthesis in the 
liver manifests itself by the decrease of albumin 
concentration.   
Melatonin is known to reveal the beneficial 
effects to decrease the LPO activation by several 
ways. Melatonin is capable of directly scavenging the 
highly reactive radicals, including hydroxyl radical, 
superoxide anion radical, singlet oxygen, hydrogen 
peroxide [27, 28].  The administration of melatonin 
clearly had a greater stimulatory effect on antioxidant 
enzymes activity [11] and our data confirm this 
action on SOD and catalase activity in gingival and 
liver tissues. 
Melatonin is also effective to inhibit the stress-
induced hormonal changes [7, 29], which are the 
factors which initiate the LPO in stress. We guess 
that melatonin effects on components of gingival 
connective tissue are explained not only antioxidant 
action, but also hormonal effects particularly cortisol 
inhibition. It’s known that cortisol is capable to 
inhibit collagen and proteoglycans synthesis. 
The comparison of the effects of two doses of 
melatonin is shown in our investigation, and 
established the higher efficiency of 1,0 mg per kg 
b.w. dose against 0,2 mg per kg b.w. The 
administration of melatonin manifests the beneficial 
influence on LPO and collagen-GAG content in 
stress-nonresistant rats particularly, because they are 
insufficient in stress-limiting mechanisms. 
The obtained results revealed the high 
effectiveness of melatonin as a stress-limiting 
substance and open the prospects of using of 
melatonin and its artificial analogues for 
pharmacological treatment of stress-induced 
disorders in parodontium and liver. 
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